PRESS RELEASE published on 02/12/2025 at 11:30, 9 months 21 days ago Informations privilégiées / Autres communiqués Sensorion participe à la 48ème rencontre annuelle de l'ARO pour présenter ses thérapies novatrices contre la perte auditive Sensorion Perte Auditive Thérapies ARO Rencontre Annuelle
BRIEF published on 12/27/2024 at 07:35, 11 months 9 days ago Sensorion Completes Enrollment for Audiogene Phase 1/2 Trial Gene Therapy Sensorion Hearing Loss SENS-501 Audiogene Trial
BRIEF published on 12/27/2024 at 07:35, 11 months 9 days ago Sensorion finalise le recrutement pour l'essai de phase 1/2 d'Audiogene Thérapie Génique Sensorion Perte Auditive SENS-501 Essai Audiogene
PRESS RELEASE published on 12/27/2024 at 07:30, 11 months 9 days ago Inside Information / Other news releases Sensorion completes enrollment of the first cohort in the Audiogene Phase 1/2 gene therapy clinical trial, targeting infants with hearing loss disorders Gene Therapy Clinical Trial Sensorion Hearing Loss Disorders Audiogene
BRIEF published on 12/18/2024 at 07:35, 11 months 18 days ago Sensorion présente des résultats préliminaires positifs pour le SENS-501 Essai Clinique Thérapie Génique Innovation Biotechnologique SENS-501 Surdité Congénitale
BRIEF published on 12/18/2024 at 07:35, 11 months 18 days ago Sensorion Reports Positive Preliminary Results for SENS-501 Gene Therapy Clinical Trial SENS-501 Congenital Deafness Biotechnological Innovation
PRESS RELEASE published on 12/18/2024 at 07:30, 11 months 18 days ago Informations privilégiées / Autres communiqués Sensorion présente des données positives de l'essai clinique de Phase 1/2 de thérapie génique pour la surdité chez les nourrissons. Nouvelles données encourageantes sur SENS-501. Séminaire en ligne prévu pour 2025 Sécurité Thérapie Génique Phase 1/2 Sensorion Surdité
PRESS RELEASE published on 12/18/2024 at 07:30, 11 months 18 days ago Inside Information / Other news releases Sensorion reports positive safety data and behavioral changes in toddlers from the Audiogene Phase 1/2 Gene Therapy Clinical Trial. Plans KOL event in 2025 for further discussion Gene Therapy Clinical Trial Sensorion Hearing Loss Audiogene
BRIEF published on 11/06/2024 at 07:35, 1 year ago Sensorion to Join Key Investor Conferences in November 2024 Biotechnology Investor Conferences Sensorion Hearing Loss Therapies Gene Therapy Development
BRIEF published on 11/06/2024 at 07:35, 1 year ago Sensorion participera aux principales conférences d'investisseurs en novembre 2024 Biotechnologie Conférences D'investisseurs Sensorion Thérapies Pour La Perte Auditive Développement De La Thérapie Génique
Published on 12/05/2025 at 02:35, 10 hours 54 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 12 hours 29 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 14 hours 24 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 14 hours 29 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 13:00, 29 minutes ago Zentra Group plc: Posting of Notice of Annual General Meeting
Published on 12/05/2025 at 13:00, 29 minutes ago Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Published on 12/05/2025 at 12:05, 1 hour 23 minutes ago Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 1 hour 29 minutes ago CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 1 hour 29 minutes ago Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 08:45, 4 hours 44 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 4 hours 44 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 4 hours 46 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 19 hours 14 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 19 hours 29 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
